Daiwa Securities Group Inc. Mersana Therapeutics, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$5.65 - $7.86 $875 - $1,218	155 Added 63.01%	401 $2,000
Q3 2021 Nov 05, 2021	BUY	$8.56 - $14.47 $1,001 - $1,692	117 Added 90.7%	246 $2,000
Q4 2020 Feb 04, 2021	BUY	$16.84 - $27.59 $2,172 - $3,559	129 New	129 $3,000
Q4 2018 Feb 05, 2019	SELL	$3.45 - $9.72 $434 - $1,224	-126 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$13.56 - $18.48 $1,708 - $2,328	126 New	126 $2,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.